International Stem Cell CORP (ISCO) › Cost of RevenueInternational Stem Cell CORP (ISCO) — Cost of RevenueAnnual figures by period end, from SEC filings.2010-12-31: $725.0K2011-12-31: $1.62M2012-12-31: $1.27M2013-12-31: $1.64M2014-12-31: $1.92M2015-12-31: $2.06M2016-12-31: $1.94M2017-12-31: $2.12M2018-12-31: $4.07M2019-12-31: $3.93M2020-12-31: $2.78M2021-12-31: $2.94M2022-12-31: $3.27M2023-12-31: $3.18M2024-12-31: $3.76M2025-12-31: $4.03M$4.03M2010-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$4.03M+7.1%2026-03-30From 2025-01-012024-12-31$3.76M+18.3%2026-03-30From 2024-01-012023-12-31$3.18M-2.7%2025-03-28From 2023-01-012022-12-31$3.27M+11.4%2024-03-28From 2022-01-012021-12-31$2.94M+5.5%2023-03-30From 2021-01-012020-12-31$2.78M-29.3%2022-03-29From 2020-01-012019-12-31$3.93M-3.3%2021-03-30From 2019-01-012018-12-31$4.07M+91.8%2020-06-01From 2018-01-012017-12-31$2.12M+9.2%2019-04-15From 2017-01-012016-12-31$1.94M-5.4%2018-04-09From 2016-01-012015-12-31$2.06M+7.0%2017-03-31From 2015-01-012014-12-31$1.92M+16.9%2016-03-30From 2014-01-012013-12-31$1.64M+29.2%2015-03-30From 2013-01-012012-12-31$1.27M-21.4%2014-03-17From 2012-01-012011-12-31$1.62M+123.2%2013-03-26From 2011-01-012010-12-31$725.0K—2012-03-16From 2010-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)